Novel framework for treatment response evaluation using PSMA PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international …
Our objective was to develop version 1.0 of a novel framework for response evaluation
criteria in prostate-specific membrane antigen (PSMA) PET/CT (RECIP) and a composite …
criteria in prostate-specific membrane antigen (PSMA) PET/CT (RECIP) and a composite …
A review of artificial intelligence in prostate cancer detection on imaging
I Bhattacharya, YS Khandwala… - … advances in urology, 2022 - journals.sagepub.com
A multitude of studies have explored the role of artificial intelligence (AI) in providing
diagnostic support to radiologists, pathologists, and urologists in prostate cancer detection …
diagnostic support to radiologists, pathologists, and urologists in prostate cancer detection …
Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation
EG Arnfield, PA Thomas, MJ Roberts… - European Journal of …, 2021 - Springer
Abstract Purpose [18F] PSMA-1007 offers advantages of low urinary tracer excretion and
theoretical improved spatial resolution for imaging prostate cancer. However, non-specific …
theoretical improved spatial resolution for imaging prostate cancer. However, non-specific …
Tumor sink effect in 68Ga-PSMA-11 PET: myth or reality?
We aimed to systematically determine the impact of tumor burden on 68Ga-prostate-specific
membrane antigen-11 (68Ga-PSMA) PET biodistribution by the use of quantitative …
membrane antigen-11 (68Ga-PSMA) PET biodistribution by the use of quantitative …
[HTML][HTML] Outcomes of cytoreductive radical prostatectomy for oligometastatic prostate cancer on prostate-specific membrane antigen positron emission tomography …
Background De novo oligometastatic prostate cancer (omPCa) on prostate-specific
membrane antigen (PSMA) positron emission tomography (PET) is a new disease entity and …
membrane antigen (PSMA) positron emission tomography (PET) is a new disease entity and …
Incorporating prostate-specific membrane antigen positron emission tomography in management decisions for men with newly diagnosed or biochemically recurrent …
Context Prostate-specific membrane antigen (PSMA) is a promising molecular target for
prostate cancer (PCa) that has allowed the development of a novel diagnostic approach to …
prostate cancer (PCa) that has allowed the development of a novel diagnostic approach to …
68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer
MJ Roberts, A Morton, P Donato, S Kyle… - European journal of …, 2021 - Springer
Purpose Prostate-specific membrane antigen (PSMA) positron emission tomography (PSMA-
PET) improves prostate cancer staging. Intraprostatic PSMA intensity may predict clinically …
PET) improves prostate cancer staging. Intraprostatic PSMA intensity may predict clinically …
Prostate-specific membrane antigen PET in prostate cancer
C Lawhn-Heath, A Salavati, SC Behr, SP Rowe… - Radiology, 2021 - pubs.rsna.org
Prostate-specific membrane antigen (PSMA)–targeted radiopharmaceuticals are playing a
large role at the time of initial staging and biochemical recurrence for localizing prostate …
large role at the time of initial staging and biochemical recurrence for localizing prostate …
PET molecular imaging: a holistic review of current practice and emerging perspectives for diagnosis, therapeutic evaluation and prognosis in clinical oncology
V Duclos, A Iep, L Gomez, L Goldfarb… - International journal of …, 2021 - mdpi.com
PET/CT molecular imaging has been imposed in clinical oncological practice over the past
20 years, driven by its two well-grounded foundations: quantification and radiolabeled …
20 years, driven by its two well-grounded foundations: quantification and radiolabeled …
[HTML][HTML] External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the …
Background Different nomograms exist for the preoperative prediction of pelvic lymph-node
metastatic disease in individual patients with prostate cancer (PCa). These nomograms do …
metastatic disease in individual patients with prostate cancer (PCa). These nomograms do …